Pharmaceutical companies came up with mixed results last year, wherein state pharmaceuticals swung to losses, while private companies posted decent profits. Kalbe Farma (KLBF), whose co-founder has just passed away, booked profit attributable to owners of Rp3.38 trillion in 2022, grew 6.29% year on year (y/y), as sales rose 10.3% y/y to Rp28.9 trillion.To subscribe please click here
